DJ Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Catalyst Pharmaceuticals Inc. $(CPRX)$ rose 2.68% to $23.37 Friday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index remaining mostly unchanged at 17,928.92 and the Dow Jones Industrial Average falling 0.29% to 41,249.38.
Catalyst Pharmaceuticals Inc. closed 10.66% short of its 52-week high of $26.16, which the company reached on March 24th.
The stock outperformed some of its competitors Friday, as Johnson & Johnson $(JNJ)$ fell 0.93% to $154.22, Pfizer Inc. $(PFE)$ fell 1.15% to $22.28, and Abbott Laboratories $(ABT)$ fell 0.57% to $133.24.
Trading volume (1.6 M) eclipsed its 50-day average volume of 1.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled May 9, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
May 09, 2025 17:26 ET (21:26 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。